Bessemer Group’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,550
| Closed | -$70K | – | 2604 |
|
|
2024
Q3 | $70K | Buy |
+2,550
| New | +$70K | ﹤0.01% | 1332 |
|
|
2024
Q1 | – | Sell |
-135
| Closed | -$3K | – | 2148 |
|
|
2023
Q4 | $3K | Buy |
+135
| New | +$3K | ﹤0.01% | 1942 |
|
|
2023
Q3 | – | Sell |
-68
| Closed | -$2K | – | 2272 |
|
|
2023
Q2 | $2K | Buy |
+68
| New | +$2K | ﹤0.01% | 2052 |
|
|
2022
Q3 | – | Sell |
-398
| Closed | -$7K | – | 2118 |
|
|
2022
Q2 | $7K | Hold |
398
| – | – | ﹤0.01% | 1452 |
|
|
2022
Q1 | $10K | Hold |
398
| – | – | ﹤0.01% | 1388 |
|
|
2021
Q4 | $11K | Hold |
398
| – | – | ﹤0.01% | 1400 |
|
|
2021
Q3 | $13K | Hold |
398
| – | – | ﹤0.01% | 1315 |
|
|
2021
Q2 | $12K | Hold |
398
| – | – | ﹤0.01% | 1315 |
|
|
2021
Q1 | $12K | Buy |
+398
| New | +$12K | ﹤0.01% | 1272 |
|
|
2018
Q4 | – | Sell |
-50
| Closed | -$2K | – | 2019 |
|
|
2018
Q3 | $2K | Buy |
+50
| New | +$2K | ﹤0.01% | 1766 |
|
|
2016
Q3 | – | Sell |
-202,035
| Closed | -$6.18M | – | 1858 |
|
|
2016
Q2 | $6.18M | Buy |
202,035
+69,390
| +52% | +$2.12M | 0.03% | 268 |
|
|
2016
Q1 | $4.97M | Buy |
+132,645
| New | +$4.97M | 0.03% | 291 |
|
|
2015
Q3 | – | Sell |
-33,217
| Closed | -$1.13M | – | 1694 |
|
|
2015
Q2 | $1.13M | Hold |
33,217
| – | – | 0.01% | 523 |
|
|
2015
Q1 | $1.18M | Buy |
33,217
+6,317
| +23% | +$223K | 0.01% | 502 |
|
|
2014
Q4 | $916K | Buy |
+26,900
| New | +$916K | ﹤0.01% | 490 |
|
|
2014
Q2 | – | Sell |
-3,200
| Closed | -$109K | – | 1452 |
|
|
2014
Q1 | $109K | Sell |
3,200
-296,800
| -99% | -$10.1M | ﹤0.01% | 721 |
|
|
2013
Q4 | $6.29M | Buy |
+300,000
| New | +$6.29M | 0.05% | 195 |
|
|
2013
Q3 | – | Sell |
-178,574
| Closed | -$4.8M | – | 1334 |
|
|
2013
Q2 | $4.8M | Buy |
+178,574
| New | +$4.8M | 0.04% | 209 |
|